# Use of Low-dose Zolpidem in Parkinson's Disease

> **NCT03621046** · PHASE2 · COMPLETED · sponsor: **Aston University** · enrollment: 28 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Zolpidem
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03621046
- **Lead sponsor:** Aston University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-20
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-01-24
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03621046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03621046, "Use of Low-dose Zolpidem in Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03621046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*